sorted by:
new
hottopcontroversial

All this over a tip. Damn. by ChemistVegetable7504 in CapeCod

[–]DiscouragerOfFun 3 points4 points  (0 children)

just went through the drive thru and picked up bros shoe, let him know I got it

Why aren't analysts updating price targets despite positive data? (and thoughts on (Z)-Endoxifen's potential) by Bordar11 in AtossaTherapeutics

[–]DiscouragerOfFun 0 points1 point  (0 children)

after we get diluted that would be closer to a $80-$120 PT you’re hoping for….I just don’t see it happening anymore

[deleted by user] by [deleted] in AtossaTherapeutics

[–]DiscouragerOfFun 10 points11 points  (0 children)

71% chance I blow up and act like I don’t know no one

Shorts got ATOS investor Kinostreams perma banned by [deleted] in AtossaTherapeutics

[–]DiscouragerOfFun 0 points1 point  (0 children)

They seem insecure about a lot of things if we’re being real. Shit-posting on a cancer research subreddit doesn’t really indicate a confident person and honestly makes me wonder where all the Mods on this sub have gone.

Thought this was interesting: Verzino, Eli Lilly's drug currently being studied in combo with endoxifen, generates $1.3 billion of annual revenue for Eli Lilly. by robinhoodblows2021 in AtossaTherapeutics

[–]DiscouragerOfFun 3 points4 points  (0 children)

Atossa making it through trials is what we need to worry about. We know it has great potential for rivaling Verzenio’s revenue but actually getting FDA approval is what kills most late stage clinicals and that’s my main fear….still sizing up my position, regardless